Should You Buy Vycor Medical, Inc. Stock in 2026?
According to the CirclFi Deep Alpha Valuation Engine, Vycor Medical, Inc. (VYCO) carries a solid Quality of Company rating of 6.0/10. Trading at $0.06, our multi-model framework evaluates whether the company's financial profile offers a favorable risk-reward setup.
The short answer: 2 of 3 CirclFi valuation models project upside for Vycor Medical, Inc. (VYCO) at $0.06 — the model consensus leans bullish, with a Quality Score of 6.0/10 and Value-Trap risk of 26/100. The full bull case, bear case, and risk factors are below. Educational analysis, not financial advice.
What Is the Investment Case for Vycor Medical, Inc. (VYCO) in 2026?
What Is the Bull Case vs the Bear Case for Vycor Medical, Inc. (VYCO)?
| Bull case — $0.07 target (+33.0%) | Bear case — $0.04 target (-22.0%) |
|---|---|
| According to the CirclFi Deep Alpha Valuation Engine, 2 of 3 models identify upside from $0.06 to a median fair value of $0.06, indicating the market hasn't fully priced in Vycor Medical, Inc.'s earnings power. | According to the CirclFi Deep Alpha Valuation Engine, the Sentiment SOTP model sees the stock as overvalued with a fair value of $0.04 (-22.0%), suggesting that the market price embeds overly optimistic growth assumptions. |
| According to the CirclFi Deep Alpha Valuation Engine, the First Chicago model targets a fair value of $0.07 (+33.0%), anchoring the bull case with a methodology that evaluates base, bull, and bear scenarios simultaneously. | According to the CirclFi Deep Alpha Valuation Engine, model disagreement is high with a +55.0% spread between the most bullish and bearish models, signaling elevated analytical uncertainty. |
| Industry tailwind: licensing and M&A optionality could provide meaningful support for Vycor Medical, Inc.'s revenue and margin trajectory in the Medical Devices space. | Industry headwind: generic/biosimilar competition represents a meaningful risk for Vycor Medical, Inc. and its Medical Devices peers. |
How Does VYCO Compare to Its Medical Devices Peers?
Valuation data pages: AIDX · SSII · NMTC · BTCY · RPID · LAB · ALUR · PEN · MXCT · IRMD · PODD
Which Other Stocks Score Like VYCO on Quality?
Closest companies to VYCO’s Quality of Company score of 6.0/10, across all industries.
- UMH — UMH Properties, Inc. (QOC 6.0) · analysis
- TPCS — TechPrecision Corporation (QOC 6.0) · analysis
- IE — Ivanhoe Electric Inc. (QOC 6.0) · analysis
- KLNG — Koil Energy Solutions, Inc. (QOC 6.0) · analysis
- MOGU — MOGU Inc. (QOC 6.0) · analysis
- MPT — Medical Properties Trust, Inc. (QOC 6.0) · analysis
- NVDA — NVIDIA Corporation (QOC 10.0) · analysis
Which Medical Devices Screens Does VYCO Appear In?
So Is Vycor Medical, Inc. (VYCO) Worth Buying in 2026?
The balance of evidence tilts cautiously positive for Vycor Medical, Inc. at $0.06. 2 of 3 models support upside to $0.06, backed by a 6.0/10 quality foundation. This is a "lean into, not load up on" setup in our framework.
These are quantitative model outputs, not investment recommendations. Vycor Medical, Inc.'s future depends on factors — management execution, competitive dynamics, regulatory changes — that no algorithm can fully capture. See all 13 model estimates →
What Else Do Investors Ask About VYCO Stock?
Should I buy VYCO stock right now?
Based on CirclFi's multi-model analysis, 2 of 3 models see upside for VYCO at $0.06. The majority of models suggest the stock trades below fair value, but investors should weigh this against the Quality Score of 6.0/10 and individual risk tolerance. This is not a buy recommendation — see our full disclaimer.
What are the biggest risks of investing in Vycor Medical, Inc.?
Key risks include: limited model coverage (3/13 active), reducing analytical confidence; general market and sector-specific risks affecting Medical Devices companies. Always diversify and consult a financial advisor.
How does VYCO compare to its competitors?
Among Medical Devices peers, VYCO holds a Quality Score of 6.0/10. Comparable companies include AIDX (QOC 6.0), SSII (QOC 6.0), NMTC (QOC 6.1). The relative ranking helps investors identify whether VYCO offers better fundamental quality than alternatives in the same sector.
Is VYCO a good long-term investment?
Long-term investment potential depends on fundamental quality and sustainable competitive advantages. VYCO's Quality Score of 6.0/10 suggests moderate fundamentals — not a clear long-term hold without further research into growth catalysts. Check our full data page for all 13 model estimates.
What price should I buy VYCO at?
CirclFi does not provide target buy prices or price alerts. However, our 3 active models produce fair value estimates ranging from $0.04 to $0.07. At $0.06, the stock trades within the range of model estimates. Many value investors look for a 20-30% margin of safety below intrinsic value before buying.
Want the complete picture?
See all 13 model estimates, confidence scores, and the full valuation table for VYCO.
Disclaimer: This article is produced by the CirclFi Valuation Engine using quantitative models and is for educational and informational purposes only. It is not financial advice, a buy/sell recommendation, or a solicitation to trade securities. Past performance is not indicative of future results. All data sourced from SEC EDGAR, FRED, and GDELT. Consult a licensed financial advisor before making investment decisions. Full disclaimer →
Buy with Gumroad